首页> 外文OA文献 >Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation
【2h】

Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation

机译:自体造血干细胞移植后复发的皮下脂膜炎样T细胞淋巴瘤中的环孢菌素

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。
获取外文期刊封面目录资料

摘要

Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare T-cell lymphoma characterized by involvement of the subcutaneous tissue of neoplastic T lymphocytes. SPTCL with hemophagocytic syndrome (HPS) is associated with an aggressive clinical course and treatment of SPTCL with HPS is not well established. Cyclophosphamide, doxorubicin, vincristine, prednisolone (CHOP) therapy is not successful in most patients suffering from SPTCL with HPS. The role of high dose chemotherapy followed by hematopoietic stem cell transplantation (HSCT) remains controversial. We report a case of relapsed SPTCL after CHOP chemotherapy and salvage chemotherapy followed by autologous HSCT, which had rapid improvement within weeks after cyclosporine and prednisolone. Immunosuppressive therapy may be an important and successful treatment option in SPTCL patients, even though they may have clinically aggressive disease.
机译:皮下脂膜炎样T细胞淋巴瘤(SPTCL)是一种罕见的T细胞淋巴瘤,其特征是肿瘤性T淋巴细胞的皮下组织受累。患有吞噬细胞综合征(HPS)的SPTCL与积极的临床病程相关,因此尚不清楚用HPS治疗SPTCL。对于大多数患有HPS的SPTCL的患者,环磷酰胺,阿霉素,长春新碱,泼尼松龙(CHOP)治疗并不成功。高剂量化学疗法继之造血干细胞移植(HSCT)的作用仍存在争议。我们报道一例CHOP和挽救性化疗后继发自体HSCT的SPTCL复发病例,后者在环孢霉素和泼尼松龙后数周内迅速好转。免疫抑制疗法可能是SPTCL患者的重要且成功的治疗选择,即使他们可能患有临床侵袭性疾病。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号